We examined the molecular mechanisms of resistance to kanamycin and viomycin in Mycobacterium smegmatis. All of the M. smegmatis strains with high-level kanamycin resistance had a nucleotide substitution from A to G at position 1389 of the 16S rRNA gene (rrs). This position is equivalent to position 1408 of Escherichia coli, and mutation at this position is known to cause aminoglycoside resistance. Mutations from G to A or G to T at position 1473 of the M. smegmatis rrs gene were found in viomycin-resistant mutants which had been designated vicB mutants in our earlier studies. Using the M. smegmatis conjugation system, we confirmed that these mutations indeed contributed to kanamycin and viomycin resistance, and kanamycin susceptibility was dominant over resistance in a heterogenomic strain. Additional experiments showed that three of four Mycobacterium tuberculosis strains with high-level kanamycin resistance had a mutation from A to G at position 1400, which was equivalent to position 1389 of M. smegmatis.
Recent advances in mycobacterial genetics have made it possible to clarify molecular changes in drug-resistant Mycobacterium tuberculosis strains. About 95% of rifampin-resistant strains have one or two mutations in the RNA polymerase ␤-subunit gene (23, 24) . Resistance to streptomycin is due to a mutation in either the ribosomal S12 protein gene (rpsL) or the 16S rRNA gene (rrs) (6) . It is also known that resistance to isoniazid is due to changes in the catalase-peroxidase gene (katG) (8) or the inhA gene (2) .
Kanamycin has been used as an important second-line antituberculosis drug for more than 30 years in Japan. This drug inhibits protein synthesis and interacts directly with ribosomes, similar to streptomycin and other aminoglycoside antibiotics (11) . We have previously shown with in vitro polyphenylalanine-synthesizing systems that kanamycin-resistant Mycobacterium smegmatis had altered ribosomes which showed resistance to kanamycin (13) .
In Escherichia coli, methylation of position 1405 or 1408 or a nucleotide change at position 1491 of the rrs gene causes resistance to kanamycin and some aminoglycoside antibiotics (3, 5) . It appears possible that in mycobacteria, resistance to kanamycin is also conferred by the mutation in the rrs gene.
Viomycin and capreomycin, basic peptide antibiotics, also inhibit procaryotic protein synthesis and have been used as second-line antituberculosis drugs. Our earlier studies have shown that resistance to viomycin and capreomycin in M. smegmatis was caused by an altered RNA molecule in the 30S or 50S ribosomal subunit (29) .
In this study, we analyzed the molecular mechanism of resistance to kanamycin and viomycin in M. smegmatis and found that one resistant mutant possessed one mutation in the rrs gene. We then confirmed the results by use of the conjugation system which had been described previously (25) . Furthermore, we examined mutational sites of drug-resistant clinical isolates of M. tuberculosis.
MATERIALS AND METHODS
Bacterial strains and media. For descriptions of M. smegmatis strains derived from strains Rabinowitchi (R), PM5 (P), and ATCC 14468 and conjugants obtained from conjugations between R and P strains, see Tables 1, 2 , and 4. Methods for isolation of drug-resistant mutants and their genotypic characteristics were described previously (21) . Briefly, the mutants were isolated by inoculating large amounts of cells, with or without UV irradiation, on medium containing 10 or 100 g of kanamycin per ml or 20 g of viomycin per ml. Frequencies of drug resistant mutants were very low even in the case of UVirradiated cells (approximately 10 Ϫ9 ), but mutants could be obtained by singlestep isolation. Strains E, M, A, and O-1 were isolated from ATCC 14468 by Yamada et al. by resistance to viomycin, but they showed pleiotropic drugresistant phenotypes (27) . The mutational sites for the resistance to kanamycin, viomycin, and streptomycin of these mutants have been characterized as being on the ribosomal subunits (14, 15, 27) . Strains AC21, AC22, and AC23 were isolated by resistance to kanamycin but showed divergent levels of resistance. For characteristics of the conjugants obtained from conjugations between R44 and P18, R36 and P18, and R17 and P31, see Table 4 .
Multiple drug-resistant clinical isolates of M. tuberculosis (see Table 5 ) were donated from Higashi Hospital and Nougata Central Hospital in Fukuoka, Japan. Nine of them were rifampin resistant and possessed a point mutation in the rpoB gene (23) . Four of them showed a high level of resistance to kanamycin (MICs, Ͼ200 g/ml). One strain also showed a high level of resistance to viomycin. MICs for M. tuberculosis or M. smegmatis were determined by a method described previously (21, 23) . Media used for M. tuberculosis were 7H9 and 7H10 (Difco Laboratories, Detroit, Mich.) and Ogawa's egg medium (Nissui Seiyaku Co., Ltd., Tokyo, Japan). For M. smegmatis, nutrient agar medium and Davis minimal medium were employed.
DNA extraction, PCR amplification, and nucleotide sequencing. The method of DNA extraction and conditions for PCR amplification have been described previously (23) . PCR amplification was performed with the Program Temp Control System PC-700 (Astec Co. Ltd., Tokyo, Japan) and a Takara Ex Taq Kit (Takara Shuzo Co. Ltd., Kyoto, Japan). Fourteen different primers ( Fig. 1) were prepared on the basis of the sequences reported by Ji et al. (9) and Rogall et al. (18) and GenBank accession number Z17212, and these were used for the amplification of the rrs gene of M. smegmatis and its flanking regions. In particular, primers f14 and r10 or r15 were used for the detection of a mutational site causing kanamycin or viomycin resistance in M. smegmatis and M. tuberculosis. The mutational sites in the rpsL genes of streptomycin-resistant M. smegmatis and M. tuberculosis strains were detected by using primers f1 (5Ј-CCAACCAT CCATCCAGCAGCTGGT-3Ј) and r1 (5Ј-CTAGCGGGATCC TTCTCCTTCT TGGCGCCGTA-3Ј) (17) . All of the streptomycin-resistant mutants of M. smeg-matis R and P strains (str-7, str-15, str-23, and str-24 mutants) had the altered rpsL gene (AAG changed to AGG at codon 43). Synthesized primers were purchased from Greiner Japan Co. Ltd. (Kyoto, Japan).
The nucleotide sequencing reaction was carried out by using Dye Terminator Cycle Sequencing FS Ready Reaction Kits with a CATALYST 800 Molecular Biology Labstation (Perkin-Elmer Japan Co. Ltd., Tokyo, Japan). The nucleotide sequence was analyzed with an ABI 373A DNA sequencer (Perkin-Elmer Japan Co. Ltd.).
Conjugation of M. smegmatis. A method described previously was employed for the conjugation of M. smegmatis (25) . Briefly, cell suspensions of equal concentrations of the parental strains (R44, R36, or R17 as a donor strain and P18 or P31 as a recipient strain) were mixed, plated on nutrient agar plates, and incubated for 48 h at 37°C. Cells grown on the agar plates were harvested, suspended in phosphate-buffered saline (0.8% NaCl, 0.02% KCl, 0.115% Na 2 HPO 4 , 0.02% KH 2 PO 4 ), and diluted appropriately. Conjugants were selected by resistance to antibiotics (nutrient agar medium supplemented with 25 g of kanamycin per ml, 12.5 g of viomycin per ml, and/or 100 g of streptomycin per ml) or by nutritional requirements (Davis minimal medium supplemented with 10 g of amino acids per ml) and were analyzed for their rrs genes.
Nucleotide sequence accession numbers. The nucleotide sequence data for the flanking regions and the spacer genes of R44 and P18 will appear in the DDBJ, EMBL, and GenBank nucleotide sequence databases with the accession numbers AB003595, AB003596, AB003597, and AB003598.
RESULTS
Nucleotide sequence analysis of 16S rRNA genes of wildtype M. smegmatis R and P strains. First, we determined the complete nucleotide sequences of the 16S rRNA (rrs) genes, the flanking regions, and the spacer genes of the kanamycinand viomycin-sensitive M. smegmatis strains R41 and P16 (Table 1 and Fig. 1 ). The nucleotide sequences of the rrs genes were compared to that of M. smegmatis ATCC 14468 (18) . The flanking regions and the spacer genes were compared to those of M. smegmatis NCTC8159 (9) . The results are shown in Fig.  2 . The nucleotide sequence of the rrs gene of the R strain was identical to that of strain ATCC 14468. The difference between the nucleotide sequences of the rrs genes of the R and P strains was minimal; only one base at position 177 was different. In contrast, the nucleotide sequences of the flanking regions and the spacer genes were different for strain NCTC8159 and the R and P strains (Fig. 2) . In particular, there was a great difference between the nucleotide sequences of the spacer genes. These differences allowed us to identify the donor of the rrs gene in kanamycin-or viomycin-resistant recombinants.
Mutational analysis of the rrs genes of kanamycin-resistant M. smegmatis strains. Next, we determined the complete nucleotide sequences of the rrs genes, the flanking regions, and the spacer genes of the kanamycin-resistant M. smegmatis strains R42 (nek-1), R44 (nek-3), P33 (nek-14), and P34 (nek-14) and compared them to those of the kanamycin-sensitive strains R41 and P16. As shown in Table 1 , these strains had a mutation from A to G at position 1389, which is equivalent to position 1408 of E. coli. By using primers f14 and r10, we also analyzed the nucleotide sequences of the 3Ј ends of the rrs genes of kanamycin-resistant strains P31, E, M, O-1, AC21, AC22, and AC23 (Tables 1 and 2 (18) and the 23S rRNA gene (GenBank accession number Z17212). DNA fragments were amplified by using combinations of the primers listed and sequenced by the dideoxy method. Primer INr20R was specific for the spacer gene of the M. smegmatis R strain, and primer INr21P was specific for that of the P strain. Numbers in parentheses indicate the nucleotide positions of primers (Fig. 2) . o, rrs gene; s, 23S rRNA gene; --, flanking region and spacer gene. b The MICs of kanamycin and viomycin for the drug-sensitive parental strain R were 2.5 and 5 g/ml, respectively, and those for strain P were 1.25 and 10 g/ml, respectively. str, resistant to 1,000 g of streptomycin per ml; nek, resistant to 1,000 g of kanamycin and neomycin per ml; vic, resistant to 50 to 300 g of viomycin and capreomycin per ml.
c -, no mutation; numbers in parentheses indicate the mutational site in the rrs gene.
FIG. 2.
Alignment of the sequences of the rrs genes, their flanking regions, and the spacer genes of M. smegmatis (M. smeg) R, P, and NCTC8159 (NCTC) (9) . The mutation at position 1387 or 1389 (underlined and boldface T or A) causes kanamycin resistance (nek). A mutation at position 1473 (underlined and boldface G) confers viomycin resistance (vicB). The combination of the f14 and r10 primers was used to detect the nek mutation, and that of the f14 and r15 primers was used to detect the vicB mutation. The nucleotide sequences from position 191 to 1280 are omitted because there were no differences with the sequence of ATCC 14468. -, same nucleotide as in M. smegmatis NCTC8159; ‫,ء‬ deletion of the nucleotide. same mutation at the same site. In the case of the derivatives of strain ATCC 14468, mutants expressing a high level of resistance to kanamycin (MIC Ͼ 1,000 g/ml) (strains E, M, O-1, and AC21) also had the same mutation at the same site ( Table 2 ). Strains AC22 (MIC ϭ 200 g/ml) and AC23 (MIC ϭ 25 g/ml), however, had a different mutation at a different position (T to A or T to C at position 1387). Strain A, which is sensitive to kanamycin but resistant to viomycin, had no mutation in the rrs gene (Table 2) .
Mutational analysis of the rrs genes of viomycin-resistant M. smegmatis strains. The complete nucleotide sequences of the rrs genes of the viomycin-resistant M. smegmatis strains R43 (vicB3), R48 (vicA1), and P41 (vicB11) were determined and compared to those of viomycin-sensitive strains R41 and P16 (Table 1 ). The vicB mutants R43 and P41 had a mutation from G to A at position 1473. However, the vicA mutant R48 had no mutations in the rrs gene. These results suggested that a mutation at position 1473 caused viomycin resistance in vicB strains. By using primers f14 and r15, we also analyzed the nucleotide sequences of the 3Ј ends of the rrs genes of viomycin-resistant strains R36 (vicB4), P29 (vicB17), P43 (vicA12), E, M, A, and O-1. As expected, vicB mutants R36 and P29 had a mutation from G to A or G to T at position 1473. We have previously shown that vicA mutants had an altered 50S ribosomal subunit (28) , and no mutation was observed in the rrs gene of vicA mutant P43 or R48. One derivative of ATCC 14468, strain O-1, expressing a high level of resistance to viomycin (MIC ϭ 1,000 g/ml) and in which the mutation was localized on a 30S ribosomal subunit (15), also had a mutation from G to T at position 1473 in addition to a mutation causing kanamycin resistance. In contrast, no mutation at position 1473 was found in strains E and M, which had low-level viomycin resistance (Table 2 ). Strain A, in which viomycin resistance is localized on a 50S ribosomal subunit (14) like a vicA mutation, had no mutation in the 3Ј end of the rrs gene ( Table 2) .
The vicB mutations were of two types, either from G to A or from G to T at position 1473. The mutation from G to T (vicB) caused a higher level of cross-resistance to kanamycin than the mutation from G to A (Table 3) (13, 21) .
Analysis of the association between the mutation in the rrs gene and kanamycin resistance by using the conjugation system. As reported previously, in conjugation between R and P strains, the chromosome was transferred from R to P (12) . To elucidate whether the mutation at position 1389 was involved in the drug-resistant phenotype, eight conjugants in which kanamycin resistance was transferred from the donor to the recipient strain were selected from a conjugation between R44 (met nek-3) and P18 (leu his str-23) ( Table 4 ). All of the conjugants were also resistant to streptomycin and required both histidine and leucine, which indicates that only a part of the chromosome was transferred from R44 to P18. The rrs genes of the conjugants were analyzed after PCR amplification with primers f-2 and r13 for the flanking region, primers f14 and INr20R for the spacer gene of the R strain, and primers f14 and INr21P for the spacer gene of the P strain (Fig. 2) . We then determined their nucleotide sequences. The 3Ј end, and the spacer gene of all conjugants were amplified by R-specific primer INr20R and not by P-specific primer INr21P (data not shown). All of them showed a mutation from A to G at position 1389 (Table 4 ). These results indicated that the rrs genes of kanamycin-resistant conjugants were transferred from the kanamycin-resistant donor strain and that the mutation at position 1389 was associated with the kanamycin resistance. The conjugants showed a change from AAG to AGG at codon 43 of the rpsL gene, the same as in the recipient strain P18 (data not shown).
Analysis of the association between the mutation in the rrs gene and viomycin-capreomycin resistance by use of the conjugation system. Similar experiments were carried out with (Fig. 2) . The number in parentheses shows the mutational site determined by the nucleotide sequence analysis of PCR products: 1389, A3G mutation at position 1389, causing kanamycin resistance; w, wild type; 1473, G3A mutation at position 1473, causing viomycin resistance.
b Conjugants obtained from conjugation between the donor R strain and the recipient P strain. The number in parentheses shows the strain number tested. strains R36 (argA met vicB4) and P18 (leu his str-23) to verify the mutation determining the viomycin resistance (Table 4) . Three leu his vicB str conjugants were chosen, and their rrs genes were analyzed. All of them had a mutation from G to A at position 1473 (Table 4) . Furthermore, all conjugants exhibited the nucleotide sequence of donor strain R in the flanking region, the 3Ј end, and the spacer gene, like kanamycin-resistant conjugants. The results indicated that the mutation at position 1473 was involved in the viomycin resistance of M. smegmatis.
Determination of whether kanamycin susceptibility is dominant or recessive in heterogenomic strains. Bercovier et al. (4) demonstrated that M. smegmatis has two sets of rRNA operons and M. tuberculosis has only one set of rRNA operons. It is therefore necessary to determine whether M. smegmatis strains, which have one copy each of the wild-type and the resistant rRNA gene, show sensitive or resistant phenotypes, because in E. coli, resistance to kanamycin is recessive (1) . We have demonstrated previously that the nek, vicA, and vicB loci are closely linked with each other and also linked to the argA and the argB loci (21) . Stable heterogenomic conjugants which were phenotypically sensitive to antibiotics but produced resistant segregants at high frequencies were obtained when the arg locus was used as a selection marker in conjugations between drug-sensitive and -resistant strains (21) . This strongly suggested that these conjugants possessed both the wild-type and the resistant rrs genes.
To prove this possibility, we isolated three kanamycin-sensitive conjugants (RP22, RP86, and RP238), which segregated resistant cells at a high frequency, from a conjugation between R17 (met; kanamycin and neomycin sensitive) and P31 (leu his argB nek-12 str-23) ( Table 4) . As a control, three kanamycinresistant conjugants (RP152, RP165, and RP202) were also isolated by the selection of met ϩ argB from the same conjugation. These conjugants were analyzed to determine the nucleotide sequences of the 3Ј end and the spacer of the rrs gene by using primers f14 and either INr21P or INr20R. As shown in Fig. 3 , three sensitive conjugants (RP22, RP86, and RP238) were amplified by both the INr20R and INr21P primers. However, the remaining three resistant conjugants, RP152, RP169, and RP202, were amplified only by primer INr21P. The nucleotide sequence analysis revealed that the R-type rrs gene amplified by primer INr20R had no mutation and that the P-type rrs gene amplified by primer INr21P had a mutation from A to G at position 1389. These results indicated that three sensitive conjugants possessed both one wild-type and one mutated rrs gene. It was also indicated that three resistant conjugants possessed only the mutated rrs genes.
Next, we isolated two kanamycin-resistant segregants from each of the kanamycin-sensitive conjugants RP22, RP86, and RP238. The six resistant segregants were analyzed for the nucleotide sequences of the 3Ј end and the spacer of the rrs gene, using primers f14 and either INr21P or INr20R. Two of six segregants had only the P-type rrs gene. This indicated that the R-type rrs gene of the parent strain was replaced by the P-type rrs gene. However, the remaining four segregants had both the R-type and the P-type rrs genes (data not shown). The nucleotide sequence analysis revealed that not only the P-type rrs gene but also the R-type rrs gene possessed the point mutation from A to G at position 1389. This indicated that the R-type rrs gene transferred from the donor strain had acquired the point mutaion spontaneously. These results indicated that two mechanisms were present to produce drug-resistant segregants. One is an intrachromosomal recombination between the resistant and the sensitive loci which resulted in the substitution of the sensitive locus for the resistant one. The other is a mutation in the sensitive locus. These results indicated that kanamycin resistance is recessive in M. smegmatis in the same way as it is in E. coli.
Analysis of multiple drug-resistant M. tuberculosis clinical isolates. Ten drug-resistant strains of M. tuberculosis clinical isolates were analyzed for partial nucleotide sequences of the rrs gene (from primer f7 to the 3Ј end) and the rpsL gene. The nucleotide sequences of the rrs genes were compared with those reported by Suzuki et al. (22) and Kempsell et al. (10) . As shown in Table 5 , three strains (HM7, HR1, and HR5) with   FIG. 3 . Analysis of the origin of the rrs gene in the conjugants obtained from a conjugation between R17 (sensitive to kanamycin and neomycin) and P31 (nek-12). A DNA fragment containing the 3Ј end of the rrs gene and the spacer gene was amplified by PCR with the primers f14 and INr20R for detection of the R-type gene (lanes 1 to 6) or with the primers f14 and INr21P for detection of the P-type gene (lanes 7 to 12) . Amplified products were used to determine the nucleotide sequences (Table 4) high-level streptomycin resistance exhibited a mutation in the rpsL gene from lysine to arginine at codon 43 or from lysine to glutamine at codon 88. Both mutations are known to cause streptomycin resistance (6, 17) . Two mutants (HM26 and HM22) with high-level streptomycin resistance had a mutation in the rrs gene at position 513, which is also known to be involved in the resistance (6, 17) . Three mutants (HR1, HM22, and HR5) of four with high-level kanamycin resistance showed an alteration in the rrs gene from A to G at position 1400. This position is equivalent to position 1389 of M. smegmatis and position 1408 of E. coli (Fig. 4) . One mutant (HM7) which showed high-level resistance to viomycin, kanamycin, and streptomycin did not exhibit mutations at positions 1400 and 1483 (equivalent to position 1473 of M. smegmatis). Instead, it had a mutation at position 705. The streptomycin resistance of this strain was due to the change in the rpsL gene. It is not known whether the mutation at position 705 is involved in the resistance to kanamycin and viomycin. Further analysis is necessary to determine the association between the resistance phenotype and the mutation. Strains (HR4, HM6, HR2, NM53, and HR8) with low-level resistance against streptomycin, kanamycin, and/or viomycin (MIC Ͻ 50 g/ml) had no mutation in either the rpsL or the rrs gene.
DISCUSSION
In this study, we found that mutations at specific sites in the 16S rRNA gene (rrs) generated resistance to kanamycin in mycobacteria. Viomycin-capreomycin resistance was also due to a change in the rrs gene. Our previous studies with M. smegmatis showed that kanamycin resistance is due to a change in a 30S ribosomal subunit (28) and that viomycin-capreomycin resistance is conferred by at least two different genes, vicA and vicB (13, 28) . By experiments involving reconstitution of a 30S ribosomal subunit, we showed that a vicB mutant has an altered 16S rRNA (29) . We have also demonstrated that the vicA, vicB, and nek genes are closely linked with each other (13, 21) . We now could determine that mutants with high-level kanamycin resistance had an rrs gene with a mutation at position 1389. Position 1389 is equivalent to position 1408 of the E. coli rrs gene, which is known to be associated with resistance to aminoglycosides. Most recently, Sander et al. reported the same mutation at position 1408 of amikacin-, gentamicin-, and tobramycin-resistant M. smegmatis strains (20) . The vicB mutants exhibited a point mutation at position 1473 of the rrs gene. From conjugation experiments, we could confirm that these mutations were indeed associated with the drug resistance.
It is interesting that A-1389 and G-1473 are located close to each other in the secondary structure of 16S rRNA, as shown in Fig. 4 . As has been reported, viomycin and kanamycin are structurally different, but these drugs show cross-resistance in M. smegmatis and also in M. tuberculosis (13, 19, 21, 26) . De Stasio et al. (5) reported that in E. coli, a mutation at position 1491 (equivalent to position 1473 of M. smegmatis) caused resistance to kanamycin, paromomycin, and other aminoglycoside antibiotics. It is also interesting that the mutation from G to T at position 1473 appeared to cause a higher level of resistance to viomycin and kanamycin than the G-to-A mutation (Table 3) . Fourmy et al. reported that aminoglycoside antibiotics bind to the A site of 30S rRNA, which includes positions 1387, 1389, and 1473, and cause misreading of the genetic code in E. coli (7) .
We found that two strains with an intermediate level of resistance to kanamycin (AC22 and AC23) possessed a mutation at position 1387 of the rrs gene. It seems plausible that the mutation at this position is also involved in the resistance to kanamycin. Further analysis is necessary to confirm the association between the mutation and the resistance.
Among viomycin-resistant mutants of ATCC 14468, strains O-1, E, and M showed a high level of resistance to kanamycin (Table 2 ). Our present analysis showed that only strain O-1 had the mutation at position 1473 in addition to that at position 1389 of the rrs gene. Probably, both mutations, at positions 1389 and 1473, are necessary for expression of a high level of resistance to viomycin. The mutation at position 1473 alone did not cause such a high level of resistance to viomycin, as shown in Table 3 . The kanamycin-resistant phenotypes of strains E and M were also due to the changes in the rrs gene. No mutations which determine viomycin resistance were observed in the rrs genes of strains E and M. These two strains were isolated by serial transfers of the culture to medium containing increasing amounts of viomycin (27) . It seems plausible that these mutants possess another change(s) in a phenotype such as permeability, in addition to the mutation at position 1389 of the rrs gene.
In previous studies, we have noted that certain conjugant classes become heterogenomic in kanamycin and viomycin resistance (21) . It is now clear that coexistence of the resistant and the sensitive rrs genes in M. smegmatis results in phenotypically sensitive heterogenomic conjugants. This also affects frequencies of the appearance of resistant mutants, since both genes must be mutated simultaneously or sequentially to express resistance against kanamycin or viomycin. In fact, frequencies of resistant mutants are very low, especially in the case of viomycin-resistant mutants (21) .
In M. tuberculosis, three (75%) of four mutants with highlevel kanamycin resistance showed a mutation at position 1400 of the rrs gene (Table 5 ). This position is equivalent to position 1389 in M. smegmatis. Strain HM7 of M. tuberculosis showed a high level of resistance to streptomycin, kanamycin, and viomycin. This strain had an alteration in the rpsL gene which causes the resistance to streptomycin. However, no mutation was found in the rrs gene except for an A-to-G mutation at position 705. It is not known whether this alteration is associated with kanamycin and/or viomycin resistance. Further analysis is necessary to confirm the association between the resistance and the mutation at position 705.
We have shown that 50S rRNA was also involved in viomy- cin resistance in M. smegmatis (29) . It seems possible that vicA mutants possess an altered 23S rRNA gene. We are now analyzing the nucleotide sequences of vicA mutants.
